Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.56 |
| ▸ | VNN1 | O95497 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30642394 | 1.00 | LTA4H (1.00) | LTA4HALDH1A1CYP1A2CYP2D6MEN1 | |
| SCHEMBL5605047 | 0.90 | LTA4H (0.82) | LTA4HALDH1A1CYP1A2CYP2D6MEN1 | |
| Acetic Acid SCHEMBL28215808 | 0.90 | LTA4H (0.81) | LTA4HALDH1A1CYP1A2MEN1MAPT | |
| SCHEMBL6730389 | 0.90 | LTA4H (0.81) | LTA4HALDH1A1CYP1A2CYP2D6MEN1 | |
| SCHEMBL4805011 | 0.89 | LTA4H (0.79) | LTA4HALDH1A1CYP1A2CYP2D6MEN1 | |
| SCHEMBL6833672 | 0.85 | LTA4H (0.73) | LTA4HALDH1A1CYP1A2CYP2D6MEN1 | |
| SCHEMBL1923699 | 0.84 | KCNH3 (0.73) | LTA4HALDH1A1CYP1A2CYP2D6CYP3A4 | |
| SCHEMBL10371775 | 0.84 | LTA4H (0.72) | LTA4HALDH1A1CYP1A2CYP2D6MEN1 | |
| SCHEMBL6730610 | 0.84 | LTA4H (0.72) | LTA4HALDH1A1CYP1A2CYP2D6MEN1 | |
| SCHEMBL171745 | 0.84 | ALDH1A1 (1.00) | LTA4HALDH1A1CYP1A2CYP2D6MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119110720-A | Cosmetic composition | 布茨公司 | 2024-12-10 | — | — | CN | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20220185793-A1 | COMPOUNDS FOR THE TREATMENT OF ONCOVIRUS INDUCED CANCER AND METHODS OF USE THEREOF | CELLESTIA BIOTECH AG (CH) | 2022-06-16 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| CN-108025189-B | Molecules having pesticidal utility, and intermediates, compositions and methods related thereto | 美国陶氏益农公司 | 2021-07-02 | — | — | CN | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| CN-102365255-B | Method for producing alcohol compound and catalyst therefor | SUMITOMO CHEMICAL CO | 2015-01-07 | — | — | CN | disclosed |
| EP-2129788-B1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS LLC (US) | 2014-09-03 | — | — | EP | disclosed |
| EP-2129788-B1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS LLC (US) | 2014-09-03 | — | — | EP | disclosed |
| US-8642014-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2014-02-04 | — | — | US | disclosed |
| WO-2002100825-A2 | ANTHRANILIC ACID AMIDES WITH A HETEROARYLSULFONYL SIDE CHAIN, AND USE THEREOF AS ANTIARRHYTHMIC ACTIVE SUBSTANCES | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-12-19 | — | — | WO | disclosed |
| US-5424436-A | Processes for the synthesis of unsymmetrical secondary amines | REILLY INDUSTRIES, INC. (US) | 1995-06-13 | — | — | US | disclosed |
| EP-0598962-A1 | Imidazole derivatives as calcium channel blockers | NEUROSEARCH A/S (DK) | 1994-06-01 | — | — | EP | disclosed |
| US-5296493-A | Analgesics or antiischemics | NEUROSEARCH A/S (DK) | 1994-03-22 | — | — | US | disclosed |
| US-5252741-A | Processes for the synthesis of imines, aldehydes, and unsymmetrical secondary amines | REILLY INDUSTRIES, INC. (US) | 1993-10-12 | — | — | US | disclosed |
| EP-0548233-A1 | PROCESSES FOR THE SYNTHESIS OF IMINES, ALDEHYDES, AND UNSYMMETRICAL SECONDARY AMINES. | REILLY IND INC (US) | 1993-06-30 | — | — | EP | disclosed |
| WO-1992002507-A1 | PROCESSES FOR THE SYNTHESIS OF IMINES, ALDEHYDES, AND UNSYMMETRICAL SECONDARY AMINES | REILLY INDUSTRIES, INC. (US) | 1992-02-20 | — | — | WO | disclosed |
| US-4874775-A | INHIBIT PHYTOPATHOGENS | ELI LILLY AND COMPANY (US) | 1989-10-17 | — | — | US | disclosed |
| EP-0206581-A2 | Agriculturally-useful sulfonamides | ELI LILLY AND COMPANY (US) | 1986-12-30 | — | — | EP | disclosed |
| CN-86103621-A | The method of the sulphonamide of preparation agriculturally useful | — | 1986-12-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220185793-A1 | COMPOUNDS FOR THE TREATMENT OF ONCOVIRUS INDUCED CANCER AND METHODS OF USE THEREOF | TP53, HAVCR2, AQP1 | LTA4H 2745/4885ALDH1A1 819/4885CYP1A2 493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.